| Importance of HER2/NEU (C-ERB-B2) status in breast cancer: Which method is more effective to evaluate of HER-2 status? | NUKET ÖZKAVRUK ELİYATKIN,Baha ZENGEL,Safiye AKTAŞ | 175–181 |
| Pure and mixed mucinous carcinoma of the breast | Ebubekir GÜNDEŞ,Faruk AKSOY,Celalettin VATANSEV,MURAT ÇAKIR | 182–185 |
| Surgical approach to breast hamartoma and the diagnostic accuracy in preoperative biopsies | Cihad TATAR,Fazilet ERÖZGEN,Sefa TÜZÜN,Tamer KARŞIDAĞ,Erdem YILMAZ,Hüsnü AYDIN,Celal KIZILKAYA,BAHRİ ÖZER | 186–190 |
| Mastalgia in daily practice | Mehmet Celal KIZILKAYA,Fazilet ERÖZGEN,Ahmet KOCAKUŞAK,Cihad TATAR,Muzaffer AKINCI,Sefa TÜZÜN,Rafet KAPLAN | 191–194 |
| Effectiveness of the triple test and its alternatives for breast mass evaluation | MURAT BAYKARA,ZEYNEP ÖZKAN,Yeliz GÜL,Özgen ASLAN,Leyla GÜNÖR | 195–199 |
| Knowledge and attitudes of women about breast cancer, self breast examination and healthy life style behaviours | Betül ÖZEN,Handan ZİNCİR,Zeliha Kaya ERTEN,Filiz ÖZKAN,Ferhan ELMALI | 200–204 |
| Axillary boost technique on adjuvant regional lymph node irradiation in breast cancer patients | SERAP ÇATLI DİNÇ,Fatih DEMİRCİOĞLU,DİCLEHAN KILIÇ,Sevilay İREN | 205–209 |
| Chronic hematoma mimicing recurrent breast carcinoma and contribution of magnetic resonance imaging to the diagnosis | IŞIL BAŞARA AKIN,Şebnem ÖRGÜÇ,Mustafa TİRELİ | 210–214 |
| Discussion of breast atrophy in one case | TUFAN EGELİ,Fatih TAŞKESEN,Murat OKUDAN,Zülfü ARIKANOĞLU | 215–217 |
| Inflammatory pseudotumor of the breast: A rare case | Ebubekir GÜNDEŞ,Adil KARTAL,Faruk AKSOY,Hatice TOY | 218–220 |
| Apocrine carcinoma of the breast: Case report | AYKUT SOYDER,Serdar ÖZBAŞ,FÜSUN TAŞKIN,Muhan ERKUŞ | 221–224 |
| Idiopathic lobular granulomatous mastitis mimicking malignancy with clinical-radiological findings: Assessment of three cases | Aynur SOLAK,SERAP KARAARSLAN,Berhan GENÇ,Atilla ÇÖKMEZ,İLHAMİ SOLAK |